MKI67 and goblet cell carcinoma: All GCC patients' samples were divided into Ki67-weak (n= 29) and Ki67-strong (n= 31) subgroups and non-malignant samples were categorized into Ki67-weak(n= 43) and Ki67-strong(n= 40) subgroups.